© Cancer Research UK 2012 Registered charity in England and Wales ( ) and Scotland (SC041666) Cancer Research UK 2012 Registered charity in England and Wales ( ) and Scotland (SC041666) Myeloma April 2012
© Cancer Research UK 2012 Registered charity in England and Wales ( ) and Scotland (SC041666) Table One: Myeloma (C90), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK, 2009
© Cancer Research UK 2012 Registered charity in England and Wales ( ) and Scotland (SC041666) Figure One: Myeloma (C90), Average Number of New Cases Per Year and Age-Specific Incidence Rates, UK,
© Cancer Research UK 2012 Registered charity in England and Wales ( ) and Scotland (SC041666) Figure Two: Myeloma (C90), European Age-Standardised Incidence Rates, Great Britain,
© Cancer Research UK 2012 Registered charity in England and Wales ( ) and Scotland (SC041666) Figure Three: Monoclonal Gammopathy of Undetermined Significance (ICD-O /1), Average Number of New Cases Per Year and Age-Specific Incidence Rates, UK estimates based on data from HMRN region,
© Cancer Research UK 2012 Registered charity in England and Wales ( ) and Scotland (SC041666) Figure Four: Myeloma (C90), Age-Standardised One-, Five- and Ten-Year Relative Survival, England,
© Cancer Research UK 2012 Registered charity in England and Wales ( ) and Scotland (SC041666) Figure Five: Myeloma (C90), Five-Year Relative Survival by Age at Diagnosis, England,
© Cancer Research UK 2012 Registered charity in England and Wales ( ) and Scotland (SC041666) Table Two: Myeloma (C90), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2010
© Cancer Research UK 2012 Registered charity in England and Wales ( ) and Scotland (SC041666) Figure Six: Myeloma (C90), Average Number of Deaths Per Year and Age-Specific Mortality Rates, UK,
© Cancer Research UK 2012 Registered charity in England and Wales ( ) and Scotland (SC041666) Figure Seven: Myeloma (C90), European Age-Standardised Mortality Rates, UK,
© Cancer Research UK 2012 Registered charity in England and Wales ( ) and Scotland (SC041666) Table Three: Myeloma (C90), One-, Five- and Ten-Year Prevalence, UK, at 31st December 2006
© Cancer Research UK 2012 Registered charity in England and Wales ( ) and Scotland (SC041666) Table Four: Myeloma (ICD-O /3, 9732/3, 9734/3), First Line Treatments Received, HMRN Region,